¼¿ï¾Æ»êº´¿ø ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ 2019 KGOG Joint International Symposium : 2019-07-13±³À°ÀÏÀÚ : 2019-07-13
±³À°Àå¼Ò : ¼¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°´ç, ¼¼¹Ì³ª½Ç
±³À°ÁÖÁ¦ :
2019 KGOG Joint International SymposiumÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸
´ã´çÀÚ : KGOG
¿¬¶ôó : 02-512-5420
À̸ÞÀÏ :
koreagynonco@hanmail.net ±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 08:00~08:20 Recent advances in Surgical strategies for Gynecologic Cancers ¹é¹ÎÇö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 08:20~08:40 Recent advances in Target therapy in Gynecologic Cancers ½É½ÂÇõ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 08:40~09:00 Recent advances in Radiotherapy in Gynecologic Cancers Haitham M. Felimban(Security Forces Hospital)
Åä·Ð 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 09:00~09:10 Discussion ()
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 13:20~13:40 Current activity of AMC Clinical Trials ¹ÚÁ¤¿(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 13:40~14:00 Current activity of JGOG Clinical Trials Takayuki Enomoto(Niigata Univ)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 14:00~14:20 Current activity of KGOG Clinical Trials ±èÀçÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 14:20~14:40 Immuno-Oncology clinical trials status for gynecology cancers: future strategy of pembrolizumab in the clinical trials and real practice ting Haluska Paul(MSD)
Åä·Ð 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 14:40~15:00 Discussion ()
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 15:00~15:20 Recent Key Issues & Debates in the Gynecological Pathology ±è±Ô·¡(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 15:20~15:40 Next generation of Cancer Drugs in the field of Gynecologic Cancers Munekage Yamaguchi(Kumamoto Univ.)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 15:40~16:00 Advances in Lymphovenous Anastomosis for Lymphedema Treatment È«ÁØÇ¥(¿ï»êÀÇ´ë)
Åä·Ð 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°´ç 16:00~16:10 Discussion ()
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 16:30~16:45 What''s New and Background of Guideline of HGC ±è¹Ì¼±(Â÷ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 16:45~17:00 How to identify HBOC & Lynch Syndrome in Gynecologic Cancer ÀÌ¿µÀç(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 17:00~17:15 NGS: What It Is and How Does It Work? ±è¹Î±Ô(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 17:15~17:30 Application of Hereditary Predisposition to Immunotherapy ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ)
Åä·Ð 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 17:30~17:40 Discussion ()
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 16:30~16:50 Sentinel Lymph Node Mapping in Cervical Cancer ±èÁÖÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 16:50~17:10 Sentinel Lymph Node Mapping in Endometrial Cancer ¼µ¿ÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 17:10~17:30 Two Step Sentinel Lymph Node Mapping in Endometrial Cancer ±è»ó¿î(¿¬¼¼ÀÇ´ë)
Åä·Ð 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 17:30~17:40 Discussion ()
±³À°½Ã°£ 07-13 ¼¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ ¼Ò°´ç 15:00~16:00 Introduction and Clinial Trial Concept of GYN cancer : Review and Discussion Haluska, Paul(MSD)